American Academy of Neurology

Roche Diagnostics at AAN 2023


More than 6 million people in the U.S. live with Alzheimer's disease. By 2050, it's projected to be 13 million people. Finding the proper treatment is crucial, but having access to earlier diagnostic tests can help change Alzheimer’s patients' future.

We look forward to seeing you at the AAN 2023 Annual Meeting in Boston, Mass., and exploring the future of Alzheimer’s research.


Fluid Biomarkers Reflecting Alzheimer’s Disease Pathology and Their Applications in the Clinical Care Pathway

April 25, 2023
6:00-9:00 p.m. EST
Marquee Room, Omni Seaport Boston Hotel


  • Liana Apostolova, M.D., M.S., FAAN
    Professor in Alzheimer's Disease Research and Professor in Neurology, Radiology, Medical and Molecular Genetics – Indiana University School of Medicine, Barbara and Peer Baekgaard Professor in AD research
  • Marwan Sabbagh, M.D., FAAN
    Memory Disorders Program and Professor of Neurology – Barrow Neurological Institute Research Professor- University of Arizona College of Medicine – Phoenix, Clinical Professor of Neurology-Creighton University


  • Anil Nasta, M.D.
    Medical and Scientific Affairs – Roche Diagnostics
  • Maria Patru, M.D., Ph.D.
    Medical and Scientific Affairs – Roche Diagnostics


Join us for an engaging symposium, where Dr. Apostolova and Dr. Sabbagh will discuss Alzheimer’s fluid biomarkers and highlight their role in the patient pathway. This program will provide a variety of clinical cases to highlight the utility of Alzheimer’s biomarkers. A Q&A session will conclude the program.